NCT Number: NCT00309738
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin in patients with risk factors for heart disease.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
CCBR A/S, Aalborg, Denmark
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Males and females (18-75 years of age)
- At least two cardiovascular disease risk factors
- Must have been following a restrictive diet
- Diagnosis of primary hypercholesterolemia or combined dyslipidemia
Exclusion criteria
- Homozygous familial hypercholesterolemia
- Conditions which may cause secondary dyslipidemia
- Uncontrolled diabetes mellitus
- Abnormal pancreatic, liver or renal function
- Abnormal serum creatine kinase (CK) above the pre-specified level
Treatment and study plan
simvastatin
DrugPrimary outcomes
-
Percent Change From Baseline in LDL-C
Time frame: 12 weeks
Percent change from baseline in low density lipoprotein-cholesterol (LDL-C)
Secondary outcomes
-
Number of Patients Attaining NCEP LDL-C Target (< 160 mg/dL)
Time frame: 12 weeks
Number of patients attaining LDL-C target according to National Cholesterol Education Program (NCEP) criteria (< 160 mg/dL)
Sponsors and collaborators
Lead sponsor
Kowa Research Europe
Industry
Registry information
Official study title
Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease
Important dates
- Study start
- 2005
- Primary completion
- 2006
- Study completion
- 2006
- First posted
- Apr 3, 2006
- Registry last updated
- Mar 16, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
NCT07655960
Dyslipidemia, Dyslipidemias
Seoul, South Korea
View Trial DetailsLipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
NCT00001154
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia
Bethesda, Maryland, United States
View Trial DetailsA Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
NCT05421078
Dyslipidemia, Dyslipidemias
Fukuyama, Japan
View Trial DetailsA Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)
NCT01414192
Dyslipidemia, Dyslipidemias
View Trial Details